|
Video: What is a Stock Split?
|
|
Paratek Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for diseases or other public health threats for civilian, government and military use. Co.'s U.S. Food and Drug Administration approved commercial product, NUZYRA®, is a once-daily oral and intravenous antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia, and acute skin and skin structure infections caused by susceptible pathogens. SEYSARA®, is being marketed by Almirall, LLC in the U.S. as a new once-daily oral therapy for the treatment of moderate to severe acne vulgaris. According to our PRTK split history records, PRTK has had 1 split. | |
|
PRTK (PRTK) has 1 split in our PRTK split history database. The split for PRTK took place on October 31, 2014. This was a 1 for 12 reverse split, meaning for each 12 shares of PRTK owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split.
When a company such as PRTK conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the PRTK split history from start to finish, an original position size of 1000 shares would have turned into 83.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PRTK shares, starting with a $10,000 purchase of PRTK, presented on a split-history-adjusted basis factoring in the complete PRTK split history.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/21/2014 |
|
End date: |
09/21/2023 |
|
Start price/share: |
$36.12 |
|
End price/share: |
$2.23 |
|
Starting shares: |
276.85 |
|
Ending shares: |
921.16 |
|
Dividends reinvested/share: |
$31.97 |
|
Total return: |
-79.46% |
|
Average Annual Total Return: |
-15.46% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,053.93 |
|
Years: |
9.42 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/21/2014 |
|
End date: |
09/21/2023 |
|
Start price/share: |
$36.12 |
|
End price/share: |
$2.23 |
|
Dividends collected/share: |
$31.97 |
|
Total return: |
-5.31% |
|
Average Annual Total Return: |
-0.58% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,466.53 |
|
Years: |
9.42 |
|
|
|
Date |
Ratio |
10/31/2014 | 1 for 12 |
|
|